Our people

Latest

August 2022

Choose from the fantastic events happening in August 2022. Meet your goal and support a cause that helps little children diagnosed with devastating childhood cancer, neuroblastoma.
February 2022

List of all third party events happening in February 2022. Take your pick. Raise funds for research into neuroblastoma and help all children diagnosed with this cancer get the chance to grow up.
Christmas Appeal 2022

Please help us by supporting our Give A Gift Christmas Appeal which not only funds research but also supports a child with neuroblastoma! With Christmas around the corner, we have also put together simple ways that not only fund research but also supports a child with neuroblastoma!
Charity Super Supporters – Team Vixens

Team Vixens and Friends have supported Run2Cure most years since it started, and have made a big difference to the charity. We thank them for their outstanding effort and their support year-on-year.

Tim Bateman

Director, The Rockpool People and Parlour Capital, Tim Bateman is a father of three and brings a wealth of financial services experience with him. After completing an Economics and Finance Degree, Tim spent 13 years in London working in the derivatives markets. He has worked across stock broking, investment banking, and finance broking in Australasia and the United Kingdom. Among other interests, Tim runs a boutique finance broking firm and was also a franchise owner for Little Kickers, kids’
Dr Steve DuBois

Dr. DuBois is director of experimental therapeutics at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma. He conducts phase 1 and 2 clinical trials of novel targeted agents. His clinical practice focuses on providing outstanding team-based care for children and young adults with solid cancers.
Associate Professor Juliet Gray

Dr. Juliet Gray is an Associate Professor in Paediatric Oncology at the Cancer Immunology Centre, University of Southampton. She leads a translational research group focused on novel antibody immunotherapies for neuroblastoma, including preclinical evaluation of novel combinational therapies as well as early phase clinical trials.
Sarah White

Sarah is a paediatric Occupational Therapist and is passionate about working with children and families. Sarah brings 20 years experience working in private, not for profit and government health roles specifically in childhood disability and mental health. Since her daughter Isabella was diagnosed with Stage 3 Neuroblastoma in 2011, Sarah has been actively involved in creating awareness and fundraising for Neuroblastoma research.
Isabella Mannix

Isabella has a background in Marketing and Sales, with twenty years’ experience working in a variety of senior roles within the Financial Services sector and more recently the Health sector. After her daughter Georgia was diagnosed with Stage 1 Neuroblastoma in 2012, Isabella and her family have supported various childrens’ cancer charities – including the Childrens’ Cancer Institute, the Kids Cancer Project, Redkite and Neuroblastoma Australia.
Our Scientific Advisory Board
Dr Louise Causer

Louise is a medical epidemiologist and lecturer currently based at The Kirby Institute, UNSW Australia and has worked internationally both in clinical and research settings across a number of fields. Having trained and working in a highly academic setting for the past decade, Louise has direct experience and key insight into the research setting in Australia and internationally.
Jane Price

Jane Price holds a Bachelor of Arts and a Bachelor of Laws. She is a small business owner, running her own immigration consultancy business, which she has grown in a few short years into a thriving practice with a couple of employees. Jane is lucky enough to have a “pigeon-pair” of children (aged 11 & 14) and was also privileged to know Sienna Hoffman.
Rochelle Yates

Rochelle is a mother of two, and Chairman of a global logistics company where she specialises in marketing. Rochelle's career includes vast experience in events and promotions and she has brought this skill to help coordinate numerous fundraising events and activities for Neuroblastoma Australia.
Professor Andy Pearson

Prof Andy Pearson is formerly a Cancer Research UK Professor of Paediatric Oncology, at the Institute of Cancer Research and the Royal Marsden Hospital NHS Trust. During a long and distinguished career, he helped establish and led many key groups in the paediatric oncology landscape both nationally and internationally.

Run2Cure Local 2021

Run2Cure Local 2021 will take place during the month of September - Childhood Cancer Awareness Month. Help us raise awareness of neuroblastoma and choose a distance and a day to run or walk in your local area.
Emeline's Story

After months of misdiagnoses, including a middle-of-the-night emergency trip to the hospital, Emeline’s mum took her to a paediatric gastroenterologist believing her tummy issue was severe constipation. It turned out to be neuroblastoma.
What is neuroblastoma?
How common is neuroblastoma?
How dangerous is neuroblastoma?
Detection, diagnosis & staging

Most symptoms of neuroblastoma are caused by the growth of the cancer into nearby tissues or organs, or its spread to distant parts of the body such as bones or bone marrow.
Noah's Story

Our first Run2Cure 2021 Superhero, Noah Lord is a cheerful, spirited, strong-willed 3 year old, who has not let Neuroblastoma slow him down. On Saturday, September 4th 2021, he and his family will be supporting the Run2Cure 2021 to raise awareness and funds for Neuroblastoma childhood cancer.
How is it diagnosed?
Trek2Cure Neuroblastoma Tasmania 2022

Explore the spectacular trails surrounding Tasmania’s iconic Cradle Mountain. Get once in a lifetime experience and rewarded knowing you are helping pave the way to a cure for neuroblastoma.
Why does this cancer form?